A new landmark study in hyperabric medicine (HBOT) shows that breathing air (21% oxygen) at 1.3 ATA of hyperbaric pressure mobilizes stem cells! Since 2006, it became clear to us that HBOT helps the body to accelerate tissue repair and regeneration by stimulating the release of stem cells in the bone marrow What we did not know is at what pressure level this occurs at. So a team of researchers decided to try and find out and they published their results in this study. They found that a minimal pressure level of 1.3 ATA caused a significant elevation in stem cells. Moreover, the researches did not add extra oxygen into a breathing apparatus, so the results were purely based upon pressure-alone. This landmark study clearly demonstrates that pressure-alone can be a contributing factor to some of the remarkable benefits that have been documented with hyperabric oxygen therapy. More importantly, it shows that these potentially-contributing  benefits can be achieved at lower pressures and without the use of supplemental oxygen. <view study> Read Less

Lymphedema is a common complication following treatment for breast cancer, which negatively affects quality of life (QOL). This study looked at 19 women who presented with lymphedema 1 year after breast cancer treatment and offered them 40 sessions of hyperbaric oxygen therapy over a 2 month period of time. They then followed up with these women 6 months later to evaluate any changes in quality of life. The results were promising and the participants reported significant improvements in QOL. These improvement included; physical functioning, fatigue, insomnia and breast and arm symptoms. with improvements peaking at 6-month follow-up <view study> Read Less

Natural killer cells (NK) are an important part of the innate immune system that can find, target and kill cancer cells NATURALLY! This crossover randomized control trial was conducted with 16 healthy young women to investigate the effect of mild hyperabric oxygen therapy (m-HBOT) on natural killer (NK)) cells. The results found that m-HBOT at 1.4 ATA was effectively able to increase NK cells by regulating parasympathetic activity <view study> Read Less

Many veterans suffer from PTSD after returning from combat. At this time, treatments are limited and the long term consequences can be devastating for these individuals. Previous reports have demonstrated hyperbaric oxygen therapy (HBOT) to help induce neuroplasticity and improve the  clinical symptoms of veterans with treatment-resistant PTSD. In this study, researchers assessed 22 veterans diagnosed with PTSD. These veterans then received a full course of hyperbaric oxygen therapy and were re-evaluated one or more years later. The follow up evaluations revealed improvements in a variety of clinical symptoms that can positively effect quality of life <view study> Read Less

Peripheral nerve injury is an uncommon but potentially catastrophic complication of anesthesia and surgery and treatment options are limited. The authors of this study performed a review of literature, both human and animal trials, for the treatment peripheral nerve injury with hyperbaric oxygen therapy. "Overall, hyperbaric oxygen therapy was reported as beneficial in 88% (45/51) of included studies (82% of human studies and 90% of animal studies), improving nerve regeneration and/or time to recovery with no reported major adverse events" <view study> Read Less